Ambu AS 

€8.74
118
-€0.15-1.63% 11:31 Today

Statistics

Day High
8.88
Day Low
8.74
52W High
14.8
52W Low
7.56
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
0.62%
Dividend
0.05

Upcoming

Dividends

0.62%Dividend Yield
Dec 25
€0.05
Dec 24
€0.05
Dec 21
€0.04
Dec 20
€0.05
Dec 19
€0.07
10Y Growth
4.89%
5Y Growth
3.26%
3Y Growth
N/A
1Y Growth
7.75%

Earnings

5NovExpected
Q4 2025
Q1 2026
Next
0.06
0.08
0.09
0.11
Expected EPS
0.111184063427976
Actual EPS
N/A

Financials

10.09%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
809.17MRevenue
81.63MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 547A.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap120.46B
Medtronic is a major player in the medical devices sector, directly competing with Ambu in areas like patient monitoring and respiratory health products.
Boston Scientific
BSX
Mkt Cap69.27B
Boston Scientific competes with Ambu in the development and manufacturing of medical devices for various health conditions, including endoscopy products.
Baxter International
BAX
Mkt Cap13.35B
Baxter International offers a range of medical devices and equipment that overlap with Ambu's product lines, especially in the critical care and surgery sectors.
Stryker
SYK
Mkt Cap116.27B
Stryker operates in the medical technology field, offering products that compete with Ambu's, particularly in surgical and emergency care devices.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson, through its medical devices division, competes across several areas with Ambu, including surgical products and patient care.
Becton Dickinson
BDX
Mkt Cap50.32B
Becton, Dickinson and Company manufactures and sells medical devices that are in direct competition with Ambu's offerings, especially in the areas of respiratory and patient monitoring.
Intuitive Surgical
ISRG
Mkt Cap129.55B
Intuitive Surgical offers robotic-assisted surgical systems, competing with Ambu's minimally invasive surgery products.
Zimmer Biomet
ZBH
Mkt Cap18.71B
Zimmer Biomet Holdings competes with Ambu in the musculoskeletal healthcare sector, including surgical products.
Edwards Lifesciences
EW
Mkt Cap51.82B
Edwards Lifesciences competes with Ambu in the critical care and surgical products sector, particularly in heart valves and hemodynamic monitoring.
Abbott Laboratories
ABT
Mkt Cap187.45B
Abbott Laboratories offers a broad range of medical devices and diagnostics products that compete with Ambu in several healthcare areas.

About

Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.
Show more...
CEO
Britt Meelby Jensen
Employees
5384
Country
Denmark
ISIN
DK0060946788
WKN
000A2JAHY

Listings

0 Comments

Share your thoughts

FAQ

What is Ambu AS stock price today?
The current price of 547A.STU is €8.74 EUR — it has decreased by -1.63% in the past 24 hours. Watch Ambu AS stock price performance more closely on the chart.
What is Ambu AS stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Ambu AS stocks are traded under the ticker 547A.STU.
Is Ambu AS stock price growing?
547A.STU stock has fallen by -8.29% compared to the previous week, the month change is a -10.68% fall, over the last year Ambu AS has showed a -33.89% decrease.
When is the next Ambu AS earnings date?
Ambu AS is going to release the next earnings report on November 05, 2026.
What were Ambu AS earnings last quarter?
547A.STU earnings for the last quarter are 0.06 EUR per share, whereas the estimation was 0.07 EUR resulting in a -16.04% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Ambu AS revenue for the last year?
Ambu AS revenue for the last year amounts to 809.17M EUR.
What is Ambu AS net income for the last year?
547A.STU net income for the last year is 81.63M EUR.
Does Ambu AS pay dividends?
Yes, 547A.STU dividends are paid annual. The last dividend per share was 0.05 EUR. As of today, Dividend Yield (FWD)% is 0.62%.
How many employees does Ambu AS have?
As of September 09, 2026, the company has 5,384 employees.
In which sector is Ambu AS located?
Ambu AS operates in the Health & Wellness sector.
When did Ambu AS complete a stock split?
The last stock split for Ambu AS was on January 03, 2018 with a ratio of 5:1.
Where is Ambu AS headquartered?
Ambu AS is headquartered in Ballerup, Denmark.